孤儿药研发的经济学分析
x

请在关注微信后,向客服人员索取文件

篇名: 孤儿药研发的经济学分析
TITLE:
摘要: 目的:从经济学角度对我国孤儿药的研发问题进行分析,为我国孤儿药的发展与政策制定提供建议。方法:利用外部性理论和交易费用理论,分析我国药品企业对孤儿药研发积极性不高的原因,并针对这些原因提出相应的解决办法。结果:孤儿药在我国尚缺乏认定标准,其外部经济性、众多的交易费用以及较大的研发风险都会加重药品企业的经济负担,打击企业研发和生产的积极性。结论:我国药品企业可以对孤儿药实行合作研发的策略,并发挥中医药治疗的传统优势,以减少研发成本。政府应建立并发展孤儿药的制度体系,发挥税收及医保的作用,加速审批,给予医药企业市场独占权,鼓励合作研发。
ABSTRACT: OBJECTIVE: To analyze the research and development (R&D) of orphan drug in China from the respect of economics, and to provide suggestions for the development and policy formulation of orphan drug in China. METHODS: The theories of external economy and transaction costs were adopted to analyze the reasons about no enthusiasm in orphan drug R&D, and find some appropriate solutions for them. RESULTS: Orphan drug was still lack of identification standard in China. The external economy, much of transaction costs in orphan drug and R&D risk aggravated the economic burden on pharmaceutical enterprises, combated R&D and production enthusiasm of pharmaceutical enterprises. CONCLUSIONS: Chinese pharmaceutical enterprises can take part in orphan drug cooperative R&D, and play the advantage of TCM treatment so as to reduce R&D cost. The government should establish and develop orphan drug system, play the role of taxation and health insurance, accelerate approval, give market exclusivity for pharmaceutical enterprises and encourage cooperative R&D.
期刊: 2017年第28卷第32期
作者: 俞江婷,王艳翚,华东
AUTHORS: YU Jiangting,WANG Yanhui,HUA Dong
关键字: 孤儿药;外部性;交易费用;研发;经济学分析
KEYWORDS: Orphan drug; External; Transaction costs; Research and development; Economic analysis
阅读数: 341 次
本月下载数: 13 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!